⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for secondary resistance

Every month we try and update this database with for secondary resistance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory OsteosarcomaNCT04690231
Effect of Drug
Toxicity, Drug
Secondary Resis...
Apatinib Mesyla...
ifosfamide and ...
3 Years - Peking University People's Hospital
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene AlterationsNCT05242822
Solid Tumor, Ad...
Intrahepatic Ch...
Urothelial Carc...
KIN-3248
18 Years - Kinnate Biopharma
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene AlterationsNCT05242822
Solid Tumor, Ad...
Intrahepatic Ch...
Urothelial Carc...
KIN-3248
18 Years - Kinnate Biopharma
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene AlterationsNCT05242822
Solid Tumor, Ad...
Intrahepatic Ch...
Urothelial Carc...
KIN-3248
18 Years - Kinnate Biopharma
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: